2827 related articles for article (PubMed ID: 25680593)
21. Clinical usefulness of dual-time FDG PET-CT in assessment of esophageal squamous cell carcinoma.
Shum WY; Hsieh TC; Yeh JJ; Chen JH; Su CC; Liang JA; Kao CH
Eur J Radiol; 2012 May; 81(5):1024-8. PubMed ID: 21458941
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma.
Vernon MR; Maheshwari M; Schultz CJ; Michel MA; Wong SJ; Campbell BH; Massey BL; Wilson JF; Wang D
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):678-84. PubMed ID: 18262086
[TBL] [Abstract][Full Text] [Related]
23. 18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?
Kendi AT; Corey A; Magliocca KR; Nickleach DC; Galt J; Switchenko JM; El-Deiry MW; Wadsworth JT; Hudgins PA; Saba NF; Schuster DM
Eur J Radiol; 2015 Jun; 84(6):1171-6. PubMed ID: 25816993
[TBL] [Abstract][Full Text] [Related]
24. Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).
Edet-Sanson A; Dubray B; Doyeux K; Back A; Hapdey S; Modzelewski R; Bohn P; Gardin I; Vera P
Radiother Oncol; 2012 Feb; 102(2):251-7. PubMed ID: 21885145
[TBL] [Abstract][Full Text] [Related]
25. A prospective trial comparing FDG-PET/CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck.
Adkins D; Ley J; Dehdashti F; Siegel MJ; Wildes TM; Michel L; Trinkaus K; Siegel BA
Cancer Med; 2014 Dec; 3(6):1493-501. PubMed ID: 25081631
[TBL] [Abstract][Full Text] [Related]
26. 18F-fluorodeoxyglucose uptake level-based lymph node staging in oropharyngeal squamous cell cancer--role of molecular marker expression on diagnostic outcome.
Sadick M; Weiss C; Piniol R; Frey S; Hoermann K; Schoenberg SO; Sadick H
Oncol Res Treat; 2015; 38(1-2):16-22. PubMed ID: 25633529
[TBL] [Abstract][Full Text] [Related]
27. FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient.
Nakajo M; Nakajo M; Kajiya Y; Tani A; Kamiyama T; Yonekura R; Fukukura Y; Matsuzaki T; Nishimoto K; Nomoto M; Koriyama C
Clin Nucl Med; 2012 May; 37(5):475-80. PubMed ID: 22475897
[TBL] [Abstract][Full Text] [Related]
28. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
29. Residual ¹⁸F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control.
Bollineni VR; Widder J; Pruim J; Langendijk JA; Wiegman EM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e551-5. PubMed ID: 22417800
[TBL] [Abstract][Full Text] [Related]
30. FDG PET uptake as a predictor of pain response in palliative radiation therapy in patients with bone metastasis.
Adli M; Kuzhan A; Alkis H; Andic F; Yilmaz M
Radiology; 2013 Dec; 269(3):850-6. PubMed ID: 23985277
[TBL] [Abstract][Full Text] [Related]
31. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
[TBL] [Abstract][Full Text] [Related]
32. Effects of intratumoral inflammatory process on 18F-FDG uptake: pathologic and comparative study with 18F-fluoro-α-methyltyrosine PET/CT in oral squamous cell carcinoma.
Kim M; Achmad A; Higuchi T; Arisaka Y; Yokoo H; Yokoo S; Tsushima Y
J Nucl Med; 2015 Jan; 56(1):16-21. PubMed ID: 25476535
[TBL] [Abstract][Full Text] [Related]
33. Preoperative [18F]fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes.
Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; Yen TC
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1054-61. PubMed ID: 19101096
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of only 18F-fluorodeocyglucose positron emission tomography/computed tomography-positive lymph nodes in head and neck squamous cell carcinoma.
Lee SH; Huh SH; Jin SM; Rho YS; Yoon DY; Park CH
Otolaryngol Head Neck Surg; 2012 Oct; 147(4):692-8. PubMed ID: 22535915
[TBL] [Abstract][Full Text] [Related]
35. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography.
Degirmenci B; Wilson D; Laymon CM; Becker C; Mason NS; Bencherif B; Agarwal A; Luketich J; Landreneau R; Avril N
Nucl Med Commun; 2008 Jul; 29(7):614-22. PubMed ID: 18528183
[TBL] [Abstract][Full Text] [Related]
36. 18F-FDG-PET/CT for the assessment of the contralateral neck in patients with head and neck squamous cell carcinoma.
Kastrinidis N; Kuhn FP; Hany TF; Ahmad N; Huber GF; Haerle SK
Laryngoscope; 2013 May; 123(5):1210-5. PubMed ID: 23426442
[TBL] [Abstract][Full Text] [Related]
37. Is there a correlation between 18F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck?
Haerle SK; Huber GF; Hany TF; Ahmad N; Schmid DT
Eur Arch Otorhinolaryngol; 2010 Oct; 267(10):1635-40. PubMed ID: 20680640
[TBL] [Abstract][Full Text] [Related]
38. Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.
Moeller BJ; Rana V; Cannon BA; Williams MD; Sturgis EM; Ginsberg LE; Macapinlac HA; Lee JJ; Ang KK; Chao KS; Chronowski GM; Frank SJ; Morrison WH; Rosenthal DI; Weber RS; Garden AS; Lippman SM; Schwartz DL
J Clin Oncol; 2009 May; 27(15):2509-15. PubMed ID: 19332725
[TBL] [Abstract][Full Text] [Related]
39. A prospective evaluation of staging and target volume definition of lymph nodes by 18FDG PET/CT in patients with squamous cell carcinoma of thoracic esophagus.
Yu W; Fu XL; Zhang YJ; Xiang JQ; Shen L; Chang JY
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e759-65. PubMed ID: 21470788
[TBL] [Abstract][Full Text] [Related]
40. Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma.
Kuo WH; Wu YC; Wu CY; Ho KC; Chiu PH; Wang CW; Chang CJ; Yu CT; Yen TC; Lin C
Acad Radiol; 2012 Jun; 19(6):685-92. PubMed ID: 22459646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
